In summary, our meta-analysis revealed that high expression of CD34, CD133, and Nucleostemin was significantly associated with poor OS, suggesting that these stemness markers are promising prognostic factors in patients affected by esophageal cancer 60. This evidence concerns the gene PROM1 and esophageal cancer.